U S Commission on Immigration ReformBiblio.com
2 692 résultats
réf. 78499Trade paperback. Very good. Format is approximately 7.5 inches by 9 inches. 12 LIX 1 232 pages. Footnotes. Illustrations. References. Appendices. Minor wear and soiling. The Commission on Immigration Reform CIR was formed by Congress in 1990 to critically examine United States immigration policies. The bipartisan commission was chaired by the late Congresswoman Barbara Jordan the highly esteemed civil rights advocate and is often referred to as the Jordan Commission. In a series of reports submitted between 1994 and 1997 the commission analyzed the impact of current immigration policies and issued recommendations for reform. The spirit of these recommendations was to return U.S. immigration policy to its stated intentions: reuniting nuclear families providing employers with skilled workers and providing humanitarian aid to refugees. The commission's primary recommendations were to improve controls against illegal immigration revamp the refugee and asylum admission system and reduce legal immigration. As mandated by the Immigration Act of 1990 the Commission conducted more than 40 public hearings consultations and site visits in the United States and some foreign countries. This final report makes recommendations to further the goals of Americanization by setting out immigrant policies to help orient immigrants and their new communities to improve educational programs that help immigrants and their children learn English and civics and to reinforce the integrity of the naturalization process by which immigrants become citizens. The report also makes recommendations for immigration policy repeating and updating the conclusions reached in three previous reports on unlawful migration legal immigration refugee and asylum policy and making additional recommendations for reforming immigration policies. The Commission urges a renewed commitment to the education of immigrant children and a recognition that education is the primary tool of Americanization for children and adults. paperback
2006réf. 73506Washington DC: U. S. Government Printing Office 2006. Presumed First Edition First printing. Wraps. Good. iii 1 95 1 pages. Rear cover has some creasing. In his opening remarks the Chairman in part stated "Porous borders exact a high price. Ineffective immigration enforcement undermines respect for law. It threatens national security. The steady flow of illegal immigration also passes unpredictable and largely unreimbursed costs on to States and counties already struggling to maintain safe healthy and prosperous communities. That de facto unfunded mandate is draining local law enforcement health care and education budgets. Today we're convening in San Diego to learn more about the intergovernmental impact of illegal immigration and to discuss the urgent need for enhanced border security. We particularly want to hear local assessments of efforts to strengthen enforcement in what is called the internal border where undocumented aliens apply for work official documents and public benefits. As the people of this area know only too well no effort to harden or patrol the international boundary will ever be 100 percent effective. And those who enter legally but subsequently violate the terms of their visa should be detected and detained by vigilant internal enforcement systems. So we asked our witnesses this morning to give us the benefit of their experience and their guidance regarding the costs of illegal immigration and effective ways to limit those costs. The current failure of enforcement is being felt throughout the Nation as the tide of undocumented aliens swells well beyond the six traditional settlement States of California New York Texas Florida Illinois and New Jersey. As of last April legislatures in 43 States considered bills on immigration issues. Attempting to fill the vacuum left by earnest but hopelessly understaffed Federal efforts States sought to control access to education and other public benefits strengthen employment verification punish human trafficking strengthen eligibility requirements for identifying documents and voting and coordinating law enforcement. County governments and mayors have similarly taken steps to regain some control over their fiscal fate. Obviously when Washington fails to exercise sovereign control over what is pouring into the national melting pot States counties and cities feel the heat. Although difficult to quantify precisely the impact of illegal immigration on State county and city budgets is undeniably growing. According to one estimate those without a legal right to be here generate net fiscal costs approaching $10 billion nationally. The State of California is reported to have spent almost $3 billion in a single year providing services to illegal immigrants. By one estimate the county of San Diego spends more than $50 million a year to arrest jail prosecute and defend illegal immigrants. Of that Federal reimbursement covers only about $2 million. U. S. Government Printing Office paperback
2001réf. 62785Washington DC: U. S. Government Printing Office 2001. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. Minor prinitng mar on front page. iii 90 p. Includes illustrations. Serial No. 106-247. In this hearing the Committee looked at the topic of ethnic and racial disparity in cancer treatments and to raise the level of awareness of disparities in care as well as to explore possible solutions to this problem. U. S. Government Printing Office paperback
2001réf. 62759Washington DC: U. S. Government Printing Office 2001. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 95 p. Serial No. 107-2. The hearing was interested in approaches to drug "demand reduction'. U. S. Government Printing Office paperback
2005réf. 62298Washington DC: U.S. Government Printing Office 2005. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 151 p. Includes illustrations. Serial No. 109-99. The Chairman stated that "this hearing may serve to change the course of future drug funding to enable the execution of transit zone drug interdiction operations. " U.S. Government Printing Office paperback
2006réf. 62284Washington DC: U. S. Government Printing Office 2006. Presumed first edition/first printing. Hardcover. Very good. No dust jacket as issued. iv 438 p. Occasional footnotes. Serial No. 109-150. Hearing held on February 14 2006. The Congressional perspective is illustrated by the Chairman's statement that "Seldom in our history has the need for the whiltleblower's unfiltered voice been more urgent particularly in the realms of national security and intelligence. " U. S. Government Printing Office hardcover
2004réf. 66649Washington DC: U. S. Government Printing Office 2004. Presumed first edition/first printing. Wraps. Very good. iii 113 p. Illustrations. Serial No. 108-189. This is the record of an oversight hearing on cancer clinical trials. The hearing was called to examine the status of efforts to bring innovative cancer treatments to patients and discuss how to change the face of cancer into a less terminal and more treatable disease. U. S. Government Printing Office paperback
2003réf. 64423Washington DC: U.S. Government Printing Office 2003. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 159 p. Occasional footnotes. Illustrations. Serial No. 107-224. U.S. Government Printing Office paperback
2001réf. 62318Washington DC: U.S. Government Printing Office 2001. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 88 p. Includes illustrations. This hearing was held before the attacks of September 11 2001. This hearing addressed the need "in the event of mass casualties inflicted through the use of chemical biological or radiological weapons State and local public health officials will need help. They will look for timely access to Federal stockpiles of the antidotes antibiotics and vaccines necessary to save lives. " This hearing addressed the question of whether critical medicines will get there in time U.S. Government Printing Office paperback
2003réf. 63290Washington DC: U.S. Government Printing Office 2003. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 138 p. Illustrations. Serial No. 108-26. This hearing examined peer-to-peer file-sharing programs which allow users to donwload and directly share electronic files from other users on the same network. U.S. Government Printing Office paperback
2002réf. 64433Washington DC: U.S. Government Printing Office 2002. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 121 p. Illustrations. Map. Serial No. 107-93. U.S. Government Printing Office paperback
2002réf. 60144Washington DC: U. S. Government Printing Office 2002. Wraps. Very good. No dust jacket. Minor wear and soiling. iv 437 p. Serial No. 107-79. "It is the judgment of this Chair based on first-hand observations that our fighting forces are getting the short end of the stick when it comes to the subject of the encroachment on and loss of military training ranges. " U. S. Government Printing Office paperback
1998réf. 62518Washington DC: U. S. Government Printing Office 1998. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. v 702 p. Illustrations. Serial No. 105-67. The puirpose of these hearings were to provide an informational overview of the measurement of race and ethnicity in the Federal Government and to review the proposed changes to Directive 15 prior to the finalization of questions on race and ethnicity for use in the 2000 Census. This hearing record contains a wealth of information in addition to presenting a variety of perspectives. U. S. Government Printing Office paperback
2002réf. 63981Washington DC: U.S. Government Printing Office 2002. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 150 p. Includes illustrations. Serial No. 107-34. This hearing docussed on compassionate access to experimentatl drugs. Science dictated a gradual process of information gathering that often took 12 to 15 years from inception to product approval. Part of the process is to move to clinical trials for which formulations are labeled as investigational new drugs and preliminary safety data is obtained and a protocol designed before the clinical trials can move forward. The issue before the Congress was whether patients not part of the trial could otherwise be provided with the experimental drug what might save or extend their lives. U.S. Government Printing Office paperback
2002réf. 62768Washington DC: U. S. Government Printing Office 2002. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 330 p. Serial No. 107-44. This hearing focused on the Government's program for compensating familities that experience vaccine injuries in particular the operation of the National Vaccine Injury Compensation Program. The Committee Chairman expressed the opinion at the start that the program was NOT working as Congress had intended. U. S. Government Printing Office paperback
2003réf. 64431Washington DC: U.S. Government Printing Office 2003. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 182 p. Serial No. 108-20. In the aftermath of the September 11th attacks the Subcommittee chairman recognizing the report of the Gilmore Commission the Advisory Panel to Assess Domestic Response Capailitieis for Terrorism Involving Weapons of Mass Destruction felt that a new strategic paradigm was needed. Containment deterrence reaction and mutaully assured destruction no longer served to protect the fundamental security interest of the American people. The threat demaned detection prevention and a proactive preemptive approach to self-defense. U.S. Government Printing Office paperback
2003réf. 64426Washington DC: U.S. Government Printing Office 2003. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 193 p. Illustrations. Occasional footnotes. Serial No. 107-217. U.S. Government Printing Office paperback
2000réf. 66639Washington DC: U. S. Government Printing Office 2000. Presumed first edition/first printing. Wraps. Good. No dust jacket. iv 280 p. Includes illustrations. Title continues; One Hundred Sixth Congress First Session July 22 1999. Serial No. 106-126. From Wikipedia: "Human immunodeficiency virus infection / acquired immunodeficiency syndrome HIV/AIDS is a disease of the human immune system caused by the human immunodeficiency virus HIV. During the initial infection a person may experience a brief period of influenza-like illness. This is typically followed by a prolonged period without symptoms. As the illness progresses it interferes more and more with the immune system making people much more likely to get infections including opportunistic infections and tumors that do not usually affect people with working immune systems. HIV is transmitted primarily via unprotected sexual intercourse including anal and even oral sex contaminated blood transfusions and hypodermic needles and from mother to child during pregnancy delivery or breastfeeding. Some bodily fluids such as saliva and tears do not transmit HIV. Prevention of HIV infection primarily through safe sex and needle-exchange programs is a key strategy to control the spread of the disease. There is no cure or vaccine; however antiretroviral treatment can slow the course of the disease and may lead to a near-normal life expectancy. While antiretroviral treatment reduces the risk of death and complications from the disease these medications are expensive and may be associated with side effects. Genetic research indicates that HIV originated in west-central Africa during the early twentieth century. AIDS was first recognized by the Centers for Disease Control and Prevention CDC in 1981 and its cause HIV infection was identified in the early part of the decade. Since its discovery AIDS has caused nearly 30 million deaths as of 2009. As of 2010 approximately 34 million people have contracted HIV globally. AIDS is considered a pandemic a disease outbreak which is present over a large area and is actively spreading. HIV/AIDS has had a great impact on society both as an illness and as a source of discrimination. The disease also has significant economic impacts. There are many misconceptions about HIV/AIDS such as the belief that it can be transmitted by casual non-sexual contact. The disease has also become subject to many controversies involving religion." U. S. Government Printing Office paperback
2004réf. 62766Washington DC: U. S. Government Printing Office 2004. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. Front page creasted at corner. iii 179 p. Includes illustrations. Occasional footnotes. Serial No. 108-143. The Committee felt that the flu season had raised the question of whether the country was prepared to deal with a pandemic either a naturally occuring one or as an act of bioterrorism. The hearing examined the actions and planning procedures that had been taken by Federal State and local health officials to handle communicable disease outbreaks. Of particular concern were potential limitations on the vaccine supply. U. S. Government Printing Office paperback
2007réf. 64002Washington DC: U.S. Government Printing Office 2007. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. Cover has some wear and soiling. iii 632 p. Includes illustrations. Serial No. 109-202. This hearing addressed what were considered serious problems with RU-486 associated with the deaths of at least 8 women 9 life-threatening incidents 232 hospitalizations 116 blod transfusions and 88 cases of infections. U.S. Government Printing Office paperback
2002réf. 64420Washington DC: U.S. Government Printing Office 2002. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 190 p. Includes illustrations. Occasional footnotes. Serial No. 107-118. In the aftermath of the September 11th attacks the Subcommittee explored the issues and opportunities around the concept of establishing a National Identification System in the United States. U.S. Government Printing Office paperback
2003réf. 66652Washington DC: U. S. Government Printing Office 2003. Presumed first edition/first printing. Wraps. Very good. No dust jacket. iii 305 p. Illustrations. Title continues: Second Session February 22 2002. Serial No. 107-148. The subcommittee held this hearing to explore the status of the border crossings in the Southeast Arizona region. The subcommittee was considering ways to improve both the security of the borders and the efficient flow of international commerce travel and tourism. U. S. Government Printing Office paperback
2003réf. 64416Washington DC: U.S. Government Printing Office 2003. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 206 p. Serial No. 107-156. This is the record of hearings that were part of the process of assessing the impacts of the September 11th attacks and the federal response to them. U.S. Government Printing Office paperback
2001réf. 60150Washington DC: U. S. Government Printing Office 2001. Wraps. Good. No dust jacket. Cover has some wear and soiling. iv 1169 p. Includes illustrations. Serial No. 107-11. This is a detailed examination of the pardon of Marc Rich whose wife Denise apparently made substantial financial contributions which it was alledged influenced the pardon process. U. S. Government Printing Office paperback
2005réf. 66635Washington DC: U. S. Government Printing Office 2005. Presumed first edition/first printing. Wraps. Good. No dust jacket. iii 352 p. Title continues: One Hundred Eighth Congress Second Session April 1 2004. Serial No. 108-226. From Wilipedia: Medical Marajuana "Medical cannabis refers to the parts of the herb cannabis used as a physician-recommended form of medicine or herbal therapy or to synthetic forms of specific cannabinoids such as THC as a physician-recommended form of medicine. The Cannabis plant has a long history of use as medicine with historical evidence dating back to 2737 BCE. Cannabis is one of the 50 "fundamental" herbs of traditional Chinese medicine and is prescribed for a broad range of indications. One of the major criticisms of cannabis as medicine is opposition to smoking as a method of consumption. However smoking is no longer necessary due to the development of healthier methods. Today medicinal cannabis patients can use vaporizers where the essential cannabis compounds are extracted and inhaled. In addition edible cannabis which is produced in various baked goods is also available and has demonstrated longer lasting effects. The United States Food and Drug Administration FDA issued an advisory against smoked medical cannabis stating that "marijuana has a high potential for abuse has no currently accepted medical use in treatment in the United States and has a lack of accepted safety for use under medical supervision. The National Institute on Drug Abuse NIDA state that "Marijuana itself is an unlikely medication candidate for several reasons: 1 it is an unpurified plant containing numerous chemicals with unknown health effects; 2 it is typically consumed by smoking further contributing to potential adverse effects; and 3 its cognitive impairing effects may limit its utility". The Institute of Medicine run by the United States National Academy of Sciences conducted a comprehensive study in 1999 to assess the potential health benefits of cannabis and its constituent cannabinoids. The study concluded that smoking cannabis is not recommended for the treatment of any disease condition but did conclude that nausea appetite loss pain and anxiety can all be mitigated by marijuana. While the study expressed reservations about smoked cannabis due to the health risks associated with smoking the study team concluded that until another mode of ingestion was perfected that could provide the same relief as smoked cannabis there was no alternative. In addition the study pointed out the inherent difficulty in marketing a non-patentable herb. Pharmaceutical companies will not substantially profit unless there is a patent. For those reasons the Institute of Medicine concluded that there is little future in smoked cannabis as a medically approved medication. The report also concluded that for certain patients such as the terminally ill or those with debilitating symptoms the long-term risks are not of great concern. Marinol was less effective than the steroid megestrol in helping cancer patients regain lost appetites. A phase III study found no difference in effects of an oral cannabis extract or THC on appetite and quality of life QOL in patients with cancer-related anorexia-cachexia syndrome CACS to placebo. "Citing the dangers of cannabis and the lack of clinical research supporting its medicinal value" the American Society of Addiction Medicine in March 2011 issued a white paper recommending a halt to using marijuana as a medicine in U.S. states where it has been declared legal." U. S. Government Printing Office paperback